Point-of-care molecular diagnostics can provide efficient and cost-effective medical care, and they have the potential to fundamentally change our approach to global health. However, most existing approaches are not scalable to include multiple biomarkers. As a solution, we have combined commercial flat panel OLED display technology with protein microarray technology to enable high-density fluorescent, programmable, multiplexed biorecognition in a compact and disposable configuration with clinical-level sensitivity.
Download count: 0
Details
- Katchman, Benjamin (Contributor)
- Smith, Joseph (Contributor)
- Obahiagbon, Uwadiae (Contributor)
- Kesiraju, Sailaja (Contributor)
- Lee, Yong Kyun (Contributor)
- O'Brien, Barry (Contributor)
- Kaftanoglu, Korhan (Contributor)
- Blain Christen, Jennifer (Contributor)
- Anderson, Karen (Contributor)
- Biodesign Institute (Contributor)
- 2016-07-04
- Digital object identifier: 10.1038/srep29057
- Identifier TypeInternational standard serial numberIdentifier Value2045-2322
- The final version of this article, as published in Scientific Reports, can be viewed online at: https://www.nature.com/articles/srep29057, opens in a new window
Citation and reuse
Cite this item
This is a suggested citation. Consult the appropriate style guide for specific citation guidelines.
Katchman, B. A., Smith, J. T., Obahiagbon, U., Kesiraju, S., Lee, Y., O’Brien, B., . . . Anderson, K. S. (2016). Application of flat panel OLED display technology for the point-of-care detection of circulating cancer biomarkers. Scientific Reports, 6(1). doi:10.1038/srep29057